India’s Investments in Bangladesh

On May 25th, 2024, Commissioner of India in Bangladesh and Investment Adviser of Bangladesh Prime Minister jointly inaugurated a second plant of India’s pharmaceutical company, Sun Pharma, near Dhaka with a production capacity of over 1 billion tablets and capsules per year.

Key Points

The new investment is a part of the growing economic and industrial engagement between India and Bangladesh.
India is a credible partner in the growth story of Bangladesh’s Pharmaceutical Industry meeting about 30% of the Active Pharmaceutical Ingredients (API) demand of Bangladesh.
Sun Pharma is the world's fourth-largest specialty generic pharmaceutical company, operating in over 100 countries.